PFE News

Latest breaking news and updates for PFE stock.

PADCEV™ Plus KEYTRUDA™ Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery

NEW YORK & TOKYO--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced positive topline results from the Phase...

Are there any upcoming conference presentations or analyst calls where more details will be disclosed? Will the positive results affect the valuation of Astellas (4503) and its partnership with Pfizer? What impact could this have on the broader oncology pipeline and investor sentiment toward Pfizer’s oncology segment?

Clinical trials

13 days ago

Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) reported financial results for the second quarter of 2025 and reaffirmed its 2025 Revenue guidance while raising guidance(1) for Adjusted(2) dilut...

How does the current sentiment score (65) compare to historical sentiment and what does it imply for institutional sentiment? Is there any guidance on capital allocation, such as share buybacks, dividend increases, or debt reduction, that could impact shareholder returns? What are the potential risks to achieving the raised EPS guidance—regulatory, competitive, or macro‑economic factors?

Earnings

19 days ago